Engineering chimeric antigen receptor CD4 T cells for Alzheimer’s disease

48

Engineering chimeric antigen receptor CD4 T cells for Alzheimer’s disease

Tags:

Previous Article

E. coli and 'good' bacteria balanced by breastmilk in baby gut microbiomes

Engineered immune cells reduce plaques in Alzheimer’s disease

Related Posts

Broad rim lesions are a new pathological and imaging biomarker for rapid disease progression in multiple sclerosis

Broad rim lesions are a new pathological and imaging bi...

93

EEG microstates: from methodological foundations to clinical translation

EEG microstates: from methodological foundations to cli...

53

News from the T cell trogocytosis front

News from the T cell trogocytosis front

180